Dapagliflozin Comparable with Empagliflozin for Long-Term Kidney Outcomes in T2D
Patients with type 2 diabetes (T2D) exhibited similar outcomes when prescribed either empagliflozin or dapagliflozin for treating chronic kidney disease (CKD), according to data published in JAMA Internal Medicine.1 With study results showing neither drug is more effective than the other within this population, researchers agree with the current practice of not recommending either drug … Read more